Relating angiotensin‐converting enzyme inhibitors or angiotensin receptor blockers with incidence or mortality of COVID‐19

Abstract The present Perspective examined the latest evidence on the association between the use of angiotensin‐converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) and the incidence/mortality of coronavirus disease 2019 (COVID‐19). Our critical appraisal from existing litera...

Descripció completa

Dades bibliogràfiques

Autors principals:	Martin C.S. Wong, Sunny Wong, Junjie Huang, Bryan Yan
Format:	Artigo
Idioma:	Inglês
Publicat:	Oxford University Press 2020-10-01
Col·lecció:	ESC Heart Failure
Matèries:	COVID‐19 Angiotensin‐converting enzyme inhibitor Angiotensin receptor blocker Severity Mortality
Accés en línia:	https://doi.org/10.1002/ehf2.12952
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!